Lanturol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lanturol

Lanturol is fundamentally an over-the-counter dietary supplement and pharmaceutical preparation supplying Vitamin E, the collective term for a group of eight fat-soluble compounds. The preparation's active ingredient is Alpha-Tocopherol, which is the only form recognized by the body to fully meet human Vitamin E requirements. It belongs to the high-level pharmacological class of fat-soluble vitamins, a group that requires the presence of dietary fat for proper absorption and utilization within the body.


Quick Facts: Lanturol

Property Description
Active Ingredient Alpha-Tocopherol (Vitamin E)
Form Oral Soft Capsule (Kapsul Lunak)
Pharmacological Class Fat-Soluble Vitamin, Antioxidant
Common Use Prevention of Vitamin E deficiency
Origin Natural (D-alpha-tocopherol) or Synthetic (DL-alpha tocopherol)

Classification, Composition, and General Purpose

Lanturol is categorized as a single-ingredient product whose primary purpose is to provide this essential micronutrient, as Alpha-Tocopherol is not produced endogenously by the human body. The medicine is commonly available in the dosage form of an oral soft capsule, where the Alpha-Tocopherol is dissolved within an oily base like vegetable oil. This oily vehicle is necessary for intestinal absorption, supporting the concept that the compound is fat-soluble.

Its general purpose is to prevent or correct a Vitamin E deficiency and provide the body with protective capabilities against damage at the cellular level. This protection stems from its primary physiological action as a potent antioxidant. This function is clinically recognized for its role in supporting the structural integrity of red blood cells. Alpha-Tocopherol acts as a radical scavenger, stabilizing highly reactive molecules called free radicals. By performing this function, particularly within cell membranes, the preparation helps sustain the integrity and healthy functioning of cells throughout the body.

Regulatory References

  1. NIH StatPearls Vitamin E (Alpha-Tocopherol) Absorption

What side effects are possible with Lanturol?

Possible Side Effects and Safety Information

Alpha-Tocopherol, the active ingredient in Lanturol (Vitamin E), has an officially documented safety profile where adverse effects are typically associated with prolonged intake at doses that exceed the Tolerable Upper Intake Level (UL) established by government health authorities.

Officially Listed Adverse Reactions

Side effects documented in regulatory sources are classified across several System-Organ Classes. The frequency of these common reactions is often Not Known or Unspecified in standard monographs for supplementation doses.

System-Organ Class Officially Documented Effects
Gastrointestinal Disorders Nausea, diarrhea, and abdominal cramps.
Nervous System Disorders Headache and dizziness.
General Disorders Fatigue and weakness.

Serious Adverse Reactions and Safety Constraints

The most serious safety concern documented in regulatory texts relates to the Blood and Lymphatic System. High daily intake of Alpha-Tocopherol may increase the risk of bleeding or hemorrhage by interfering with Vitamin K-dependent clotting factors.

Population-Specific Safety: Safety notes identify increased risk for specific groups. This includes individuals concurrently using Vitamin K antagonists (anticoagulants) and those with a pre-existing Vitamin K deficiency.

Dose-Related Pattern: Adverse reactions and the potential for serious hematological effects are predominantly associated with chronic exposure to doses that exceed the official Tolerable Upper Intake Level (UL). The fundamental safety constraint is avoiding this excessive chronic intake.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents define the overdose profile for Lanturol based on specific clinical domains that require immediate professional attention.


Documented Overdose Profile

The regulatory labeling requires the documentation of signs, symptoms, and corresponding laboratory findings observed in human overdose cases. These manifestations define the expected immediate and delayed clinical effects of an excessive exposure to the medication.

Overdose Domain Key Regulatory Focus
Signs and Symptoms Specific clinical and laboratory manifestations documented in human overdosage.
Complications Detailing of serious risks, such as delayed acidosis or specific organ toxicity (e.g., hepatic or renal impairment), which define the severity of the event.
Emergency Procedures The officially recommended treatment protocols, including the potential use of a specific antidote, gastric decontamination, or advanced supportive measures.

When to Seek Immediate Medical Help

Any known or suspected overdose of Lanturol is considered a medical emergency and requires immediate professional intervention. The specific complications, such as organ toxicity, necessitate urgent care to manage potentially life-threatening effects. You must immediately contact emergency services (such as 9-1-1) or a certified Poison Control Center. The official treatment procedures listed in the drug's prescribing information mandate prompt activation of the emergency medical system to ensure the necessary supportive care and advanced medical management are initiated without delay.

Therapeutic Uses of Lanturol

What Lanturol Treats: Main Uses and Benefits

Lanturol's active ingredient is a form of Vitamin E (alpha-tocopherol), and its therapeutic uses are applied in situations involving certain distressing symptoms. The primary therapeutic domains are applied in contexts marked by increased discomfort or tension, relevant to supporting cellular health and blood functions.

This medication is relevant across domains where additional symptomatic support is needed. It is used for managing symptoms associated with systemic imbalance, increased neurological or muscular activity, and conditions affecting the skin or blood.

“It provides support that helps ease the overall symptom burden, contributing to improved comfort during periods of heightened symptoms.”

It is considered relevant in conditions involving episodic or fluctuating manifestations and applied when symptoms interfere with daily functioning. This supports general well-being during symptomatic phases and provides supportive relief when symptoms become more noticeable.


Quick Fact: Supportive Relief for Symptoms

This medication is applied in scenarios where additional management of discomfort is required due to symptoms linked to increased physiological stress and systemic imbalance.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who can and cannot use Lanturol?

The population eligibility for Lanturol is governed by official regulatory criteria, focusing on absolute contraindications and conditional restrictions.

Populations Permitted and Contraindicated

Use is generally established for adults and children requiring standard daily intake or those with a documented Vitamin E deficiency, especially linked to malabsorption. However, Lanturol is contraindicated in patients with known hypersensitivity to Alpha-Tocopherol or its excipients. Certain specialized formulations are also contraindicated for preterm newborn infants.


Conditional Use and Restrictions

Regulatory agencies require caution and conditional use for several populations, typically concerning high-dose supplementation.

  • Bleeding Risk: High doses are restricted and require monitoring for patients taking anticoagulants, those with Vitamin K deficiency, or those with existing bleeding disorders. High-dose supplementation must be discontinued before surgery.
  • Organ Function: Use is limited and requires professional monitoring for patients with renal impairment or underlying liver impairment due to a lack of established safety data in these groups.
  • Reproductive and Age Status: High doses are not recommended for women who are pregnant or breastfeeding, nor are they recommended for men aged 55 and older due to stated risks.

What should I know about interactions with other medicines?

The official interaction profile for Lanturol (Alpha-Tocopherol) is defined by its effects on blood coagulation and its requirement for fat-dependent absorption, as documented in government regulatory statements.

Interaction scope

Category Official Regulatory Information
Medicinal product categories with documented interactions Oral Anticoagulants (Vitamin K antagonists), Antiplatelet Agents, Bile Acid Sequestrants, Lipase Inhibitors (Orlistat), and Inorganic Iron Supplements.
Specific interacting medicines (if explicitly listed) Warfarin, Dicumarol, Cholestyramine, Mineral Oil, Orlistat, and Iron (ferrous sulfate).
Mechanistic basis of interactions (only if stated in label) Pharmacodynamic antagonism/synergism: High-dose Alpha-Tocopherol may interfere with Vitamin K-dependent coagulation factors, leading to potentiated anticoagulant effects. Reduced Absorption: Certain agents interfere with the bile acids required for this fat-soluble vitamin’s absorption.
Timing-based interaction rules (if applicable) None explicitly stated that mandate a specific administration timing (e.g., "administer X hours apart") to mitigate a critical interaction.
Population-specific interaction notes (if applicable) Patients with pre-existing Vitamin K deficiency (e.g., due to liver failure): Potentiation of anticoagulant effects may be more pronounced.

Interaction classifications (high-level)

Classification Official Regulatory Information
Interaction severity classification (as defined in official documents) Significant - Monitor Closely: Applies to the combination with oral anticoagulants. Moderate: Applies to agents that reduce absorption.
Interaction-context constraints (as defined in official documents) The most clinically significant interaction (anticoagulants) is primarily associated with high doses of Alpha-Tocopherol (often defined as >400 IU/day) in official regulatory summaries.

Resulting interaction structure

Official interaction statements:

  • Pharmacodynamic Interaction: Co-administration with Vitamin K Antagonists may potentiate the anticoagulant effect, carrying a documented risk of hemorrhage.
  • Reduced Exposure: Substances like Bile Acid Sequestrants and Mineral Oil may reduce the intestinal absorption of Alpha-Tocopherol, leading to lower systemic exposure.
  • Supplement Interference: High doses of Alpha-Tocopherol may functionally interfere with Iron supplements, potentially delaying the red blood cell response to iron therapy in certain patient populations.

Connection to the overall interaction profile: The regulatory documentation defines Lanturol's interaction structure primarily through two non-metabolic mechanisms: pharmacodynamic interference with the coagulation cascade and physical or functional inhibition of absorption for this fat-soluble vitamin. The profile consistently emphasizes that the risk of bleeding is the most significant interaction, specifically noted in patients concurrently using anticoagulants, and often linked to the administration of high doses.

Mechanism of Action

Termination of Lipid Peroxidation and Membrane Stabilization

The primary action of Alpha-Tocopherol is as a chain-breaking antioxidant operating directly within the lipid bilayer of cell membranes. It intercepts and terminates the destructive lipid peroxidation chain reaction by donating a hydrogen atom ( Hcdot) to highly reactive Peroxyl Radicals ( LOOcdot). This molecular quenching process results in the preservation of membrane structure, which is a factor in maintaining the necessary fluidity and structural integrity of all cellular components, particularly the susceptible Red Blood Cells.


Modulation of Intracellular Signaling Pathways

In addition to its antioxidant role, the molecule exerts non-antioxidant effects by directly modulating intracellular signaling. This involves suppressing the activation of key transcription factors like Nuclear Factor Kappa B ( NF-kappa B) and inhibiting specific isoforms of Protein Kinase C ( PKC). By interfering with these pathways, the mechanism results in the dampening of transcriptional signals that govern the expression of pro-inflammatory mediators, contributing to the modulation of physiological signaling dynamics at the tissue level.

Dosage and Administration Information

How to Use Lanturol

The usage of Lanturol (Alpha-Tocopherol, a form of Vitamin E) is governed by its chemical classification as a fat-soluble vitamin. The official instructions for administration are designed to optimize the absorption of the active ingredient and ensure consistent delivery.


Official Administration Guidelines

Instruction Entity Detail/Guideline
Route of administration Oral
Dosing schedule Dosing is standardized by the Recommended Dietary Allowance (RDA) for adults at 15 mg per day for maintenance. The maximum daily intake unlikely to cause adverse effects is the Tolerable Upper Intake Level (UL) of 1,000 mg.
Timing in relation to meals Must be taken with a meal or a source of dietary fat/oil to facilitate proper intestinal absorption.
Age-group administration rules Dosing is adjusted based on age-specific RDAs, with lower daily requirements for pediatric patients compared to the adult dosage.
Missed-dose rules If a dose is missed, it should be taken when remembered unless it is near the time of the next scheduled dose; in that scenario, the missed dose is typically skipped to maintain the regular regimen.

Procedural Structure

The official protocol for taking Lanturol requires administration of the oral soft capsule once daily, specifically in conjunction with dietary fat. This constraint is critical because Alpha-Tocopherol is fat-soluble and requires the presence of oil for its uptake by the body. The capsule must be swallowed whole with water and is generally used as part of a long-term regimen to maintain adequate Vitamin E status. These official instructions define the standardized approach to using the medicine.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Lanturol (Alpha-Tocopherol)

The research evidence for Lanturol’s active ingredient, Alpha-Tocopherol (a form of Vitamin E), has been studied primarily for its recognized role as an essential micronutrient. Studies have explored its use in correcting deficiencies and its function as an antioxidant in specific physiological contexts.


Research Evidence Supporting the Correction of Vitamin E Deficiency

Research has primarily focused on Alpha-Tocopherol's role in people diagnosed with very low Vitamin E levels, known as deficiency. Research examined how Alpha-Tocopherol administration impacted the key biomarker: serum alpha-tocopherol concentration. Studies also monitored outcomes related to physical discomfort and systemic or functional imbalance, such as specific neurological symptoms (e.g., ataxia).

The compound was observed in research involving children and adults with underlying fat malabsorption disorders or rare inherited genetic defects. Findings describe patterns observed in the studies where administering the compound was associated with measurable changes in serum Vitamin E levels. What remains uncertain is the applicability of these findings to the healthy population.


Studies on the Supportive Role in Oxidative Stress and Red Blood Cell Health

Studies explored the compound in research contexts involving fluctuating or unstable symptoms, particularly in relation to physiological strain or stress. This research primarily examined the compound in relation to surrogate endpoints, such as the stability of red blood cells (RBCs) and various oxidative stress biomarkers in the blood. Research was evaluated in adults and children with certain underlying blood conditions.

Findings indicate that some studies observed patterns related to certain oxidative stress markers in specific high-risk groups. However, when research examined broader populations, the findings were mixed, and evidence quality varies. Certainty remains low when data show patterns related to general chronic disease prevention in the healthy population, as evidence is limited and results apply only to the populations studied.


Key Limitations and Areas of Research Uncertainty

Research highlights that many studies rely on monitoring surrogate endpoints, such as lab biomarkers, rather than major clinical events. Furthermore, comparative evidence is lacking, and findings were mixed in large-scale trials that monitored the association between high-dose supplementation and chronic disease prevention in generally healthy adults. Long-term effects are not fully established for many supportive roles.

Key Studies & References

  1. Vitamin E Deficiency: Symptoms & Causes - Cleveland Clinic
  2. Vitamin E (Alpha-Tocopherol): MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Lanturol (FAQ)

Q: Is it true Lanturol helps with [secondary symptom/effect]?

Studies indicate Lanturol’s active ingredient is primarily used to prevent or correct Vitamin E deficiency. Regulatory research has examined its supportive roles, such as its antioxidant properties and effects on cellular integrity. However, the official evidence regarding other specific secondary benefits is often complex and sometimes contradictory.

Q: What is the difference between Lanturol and a placebo in studies?

Official regulatory documentation confirms that clinical trials for Alpha-Tocopherol have been conducted using a placebo, which is an inactive substance. Comparing the product to a placebo is a standard method used in research to evaluate effectiveness and distinguish real effects from patient expectations.

Q: Is Lanturol safe to use for long periods of time?

The use of Lanturol over a long period is generally permitted when doses remain within the official Recommended Daily Allowance (RDA). Official safety information highlights that chronic use exceeding the Tolerable Upper Intake Level (UL) is the primary factor linked to an increased risk of bleeding.

Q: Can older adults typically use Lanturol?

Lanturol is generally established for use by adults. However, high-dose supplementation in older adults may be associated with certain risks, including bleeding complications. Official guidelines indicate that professional monitoring may be warranted when Lanturol is used by older adults.

Q: Can women who may become pregnant use Lanturol?

Specific Recommended Daily Allowances (RDA) for the active ingredient are established for women who are pregnant or breastfeeding to ensure essential nutrient intake. For high-dose supplementation in these groups, consulting a healthcare provider is recommended in regulatory statements.

Q: Why is Lanturol not approved for use in all age groups?

Regulatory approval and safety documents note that dosing is specifically adjusted based on age-specific needs. Specific formulations are contraindicated for certain pediatric groups, such as preterm infants, due to known risks like necrotizing enterocolitis.

Q: Is it normal to feel tired in the first week of taking Lanturol?

Fatigue and weakness are officially documented side effects, particularly when Lanturol is taken at high doses. Regulatory labels list these effects, but they do not specify if they are expected only during the first week of therapy.

Q: Do I need any special tests or monitoring while on Lanturol?

Official information advises that patients taking high doses or those concurrently using blood thinners (anticoagulants) may need monitoring of their blood coagulation status. This monitoring helps ensure safety due to the potential for an increased risk of hemorrhage.

Q: Is Lanturol generally appropriate for people with kidney or liver issues?

Official regulatory documents indicate that there are no defined dosage adjustments for patients with existing renal (kidney) or hepatic (liver) impairment. Therefore, caution and close professional monitoring may be warranted when Lanturol is used in these populations.

Q: How quickly am I supposed to feel a difference after starting Lanturol?

The body’s absorption of Alpha-Tocopherol into the plasma begins relatively quickly, generally within a few hours of administration. However, realizing a noticeable clinical effect, particularly when correcting a deficiency, typically relies on sustained, long-term use.

Q: Can Lanturol be taken with common supplements like vitamin D or magnesium?

Regulatory documents do not list specific interactions with all common vitamins, such as Vitamin D or magnesium. Official guidance recommends sharing all prescription and over-the-counter supplements being taken with a healthcare provider.

Q: Is Lanturol considered a 'strong' medicine?

Lanturol is officially classified by regulatory agencies as a fat-soluble vitamin and a dietary supplement. The focus of official documents is on its essential nutrient role and safety profile, rather than a subjective term like 'strong.'

Q: Does Lanturol interact with alcohol?

Official safety information indicates that it is currently unknown if consuming alcohol directly impacts the absorption or effectiveness of Lanturol. General caution regarding responsible alcohol use is consistently noted in health guidance.

Q: Is Lanturol a newer medication or has it been around for a while?

The active ingredient, Alpha-Tocopherol, is a well-established substance with a long history. It was first discovered in 1922 and was successfully synthesized in 1938.

Q: Will Lanturol affect my ability to drive or operate machinery?

Officially documented side effects of Lanturol include dizziness and blurred vision. Patients are generally advised to be aware of how the product affects them before driving or operating machinery.

Q: Is Lanturol a controlled substance?

Lanturol is officially classified as a fat-soluble vitamin and a dietary supplement. It is not listed as a federally scheduled or controlled substance by national regulatory bodies.

Q: Does Lanturol interact with birth control pills?

Official product information does not list an interaction where Lanturol reduces the effectiveness of hormonal birth control. However, some research suggests that oral contraceptives may slightly lower the body’s natural plasma levels of Vitamin E.

Q: How long does Lanturol typically stay in your system?

The half-life of Alpha-Tocopherol in the blood plasma is typically reported to be about 2 to 3 days. This means it takes a few days for the concentration in the bloodstream to drop by half after administration stops.

Q: Are there any known interactions between Lanturol and herbal remedies?

While specific interactions with all herbal remedies are not listed in official regulatory documents, authoritative sources consistently recommend discussing every herbal product being used with a healthcare provider to check for possible interference.

Q: What scientific organization approved Lanturol?

Lanturol (Alpha-Tocopherol) is regulated by national governmental health bodies, such as the U.S. Food and Drug Administration (FDA). These agencies establish its status as an essential micronutrient, set safety limits, and determine the Recommended Daily Allowance (RDA).

How should Lanturol be stored and disposed of?

How to Store and Dispose of Lanturol

Lanturol (Alpha-Tocopherol) must be stored strictly according to the official regulatory requirements to maintain the stability of the soft capsules.

Official Storage Conditions

  • Temperature: Store at room temperature, maintained between 1 C and 30 C.
  • Protection: The product must be protected from light, heat, and moisture to prevent degradation.
  • Child Safety: The medicine must be kept safely out of the reach of children.

Disposal Instructions

Any unused portion of Lanturol must be discarded and is not to be stored for later use. Consult local regulations for the proper disposal method for unused or expired medicines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lanturol found in:

A-Z Index: